ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0057430 | null | Deoxy guanosine triphosphate (substance)|Deoxy guanosine triphosphate|dGTP|deoxy-GTP|Deoxy guanosine triphosphate (dGTP) | deoxyguanosine triphosphate |
C0057430 | null | Deoxy guanosine triphosphate (substance)|Deoxy guanosine triphosphate|dGTP|deoxy-GTP|Deoxy guanosine triphosphate (dGTP) | deoxyguanosine triphosphate |
C0254123 | A membrane protein homologous to the ERM (Ezrin-Radixin-Moesin) family of cytoskeleton-associated proteins which regulate physical properties of membranes. Alterations in neurofibromin 2 are the cause of NEUROFIBROMATOSIS 2. | merlin|Merlin (substance)|Schwannomin Protein|Gene Product, NF2|NF2|Schwannomin|Merlin|Moesin-Ezrin-Radixin-Like Protein|Neurofibromin 2|Neurofibromatosis Type 2 Protein|Protein, Schwannomin|NF2 Gene Product|Schwannomerlin|Neurofibromatosis 2 Gene Product|Moesin Ezrin Radixin Like Protein|Neurofibromatosis type 2 protein|Moezin-ezrin-radixin-like protein | Neurofibromin 2 |
C1098841 | null | null | epiprocurcumenol |
C1098841 | null | null | epiprocurcumenol |
C0019643 | Deacetylases that remove N-acetyl groups from amino side chains of the amino acids of HISTONES. The enzyme family can be divided into at least three structurally-defined subclasses. Class I and class II deacetylases utilize a zinc-dependent mechanism. The sirtuin histone deacetylases belong to class III and are NAD-dependent enzymes. | HDAC Proteins|Deacetylases, Histone|Histone Deacetylases|histone deacetylase|HDAC|Histone Deacetylase|Deacetylase, Histone|Histone deacetylase | Histone Deacetylase |
C0076714 | null | TIPEPIDINE|Tipepidine|tipepidine | tipepidine |
C0076714 | null | TIPEPIDINE|Tipepidine|tipepidine | tipepidine |
C0446150 | A species of DELTARETROVIRUS that includes the strains SIMIAN T-LYMPHOTROPIC VIRUS 3 and HUMAN T-LYMPHOTROPIC VIRUS 3. | Primate T-lymphotropic virus 3|Primate T-lymphotropic virus 3 (organism)|Primate T lymphotropic virus 3|PLTV-3 | Primate T-lymphotropic virus 3 |
C0237401 | A person who lives alone or a single-family member who experiences a health-related problem. | individual|Individual|Individual (person) | Individual |
C0041014 | A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3. | T3 - triiodothyronine|T-3|Triiodothyronine preparation|T3 Thyroid Hormone|3,5,3'-Triiodo-L-thyronine|T3 preparation|L-triiodothyronine preparation|t3|3,5,3'-Triiodothyronine|L-T3|L-Triiodothyronine|L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-|O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|3,5,3' Triiodothyronine|Liothyroninum|4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|LIOTHYRONINE|Thyroid Hormone, T3|therapeutic triiodothyronine|L-3,5,3'-Triiodothyronine|Therapeutic T3|Triiodothyronine|3,3',5-triiodo-L-thyronine|Liothyronine|Triiodothyronine (T3)|liothyronine|3,5,3' triiodothyronine|T3|triiodothyronine|t3 thyroid hormone|Liothyronine (substance)|3,3',5-Triiodothyronine|Liothyronine-containing product|Product containing liothyronine (medicinal product)|Liotironina | liothyronine |
C1426934 | null | ZYGOTE ARREST 1|zinc finger, 3CxxC-type 6|ZAR1|ZAR1 gene|zygote arrest 1|Z3CXXC6 | ZAR1 gene |
C1426934 | null | ZYGOTE ARREST 1|zinc finger, 3CxxC-type 6|ZAR1|ZAR1 gene|zygote arrest 1|Z3CXXC6 | ZAR1 gene |
C1521747 | The glandular tissue of the breast. In females, it is composed of numerous lobules with alveolar ducts and alveoli. In males, it is composed of rudimentary glands. | Mammary Gland Parenchyma|Mammary Gland Tissue|Breast Tissue | Mammary Gland Parenchyma |
C0949629 | The result of a positive or negative response (to drugs, for example) in one cell being passed onto other cells via the GAP JUNCTIONS or the intracellular milieu. | Effects, Bystander|Effect, Bystander|Bystander Effects|bystander effect | Bystander Effect |
C0205145 | A position in relation to its surroundings. | Site|Sites|Site (attribute) | Site |
C0029005 | Proteins coded by oncogenes. They include proteins resulting from the fusion of an oncogene and another gene (ONCOGENE PROTEINS, FUSION). | ONCOGENE PROTEINS|Product, Oncogene|Oncoproteins|Oncogene Proteins|Proteins, Oncogene|Oncogene Products|Oncogene protein, NOS|Oncogene protein product, NOS|Oncogene protein|Oncogene Protein|Oncogene Product|oncoprotein|oncogene proteins|Protein, Oncogene|Oncogene protein (substance)|Products, Oncogene|Oncoprotein, NOS|Oncoprotein|oncoproteins | Oncogene Proteins |
C0004112 | A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury. | Astrocyte|Astrocyte, NOS|astrocyte cells|Astrocytes|Astrocyte (cell)|Astroglia|Astrocytus|Astroglias|astrocytes|astroglia|astrocyte | Astrocytes |
C0075193 | An indolocarbazole that is a potent PROTEIN KINASE C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20) | (9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one|CGP-39360|STAUROSPORINE|Staurosporine|8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-|staurosporine | Staurosporine |
C0047039 | null | 3,5-DIABS | 3,5-diiodo-4-azidobenzenesulfonate |
C0047039 | null | 3,5-DIABS | 3,5-diiodo-4-azidobenzenesulfonate |
C0281361 | An adenocarcinoma which arises from the exocrine pancreas. Ductal adenocarcinoma and its variants are the most common types of pancreatic adenocarcinoma. | Pancreas Adenocarcinoma|adenocarcinoma pancreas|adenocarcinoma of pancreas|Adenocarcinoma of the pancreas|Adenocarcinoma of the Pancreas|pancreatic adenocarcinoma|Pancreatic Adenocarcinoma|adenocarcinoma of the pancreas|Adenocarcinoma - pancreas|pancreas adenocarcinoma|Adenocarcinoma of pancreas (disorder)|Adenocarcinoma of pancreas|Pancreatic adenocarcinoma|Adenocarcinoma of Pancreas | Adenocarcinoma of pancreas |
C0058381 | null | diphenylene iodonium|dibenziodolium | diphenyleneiodonium |
C0796349 | Proximal (short) arm of chromosome 17 | chromosome 17p|Chromosome 17 Short Arm|Chromosome 17p|17p|Chromosome 17 Proximal Arm | Chromosome 17 Short Arm |
C0007613 | Cellular processes, properties, and characteristics. | cell functions|Subcellular Process|Cell physiology|Phenomenon, Cell Physiological|cells physiology|Cell Physiological Phenomenon|Phenomena, Cell Physiological|cell function|cells function|Cell Physiology|Cellular Function|Cellular Process|Cell Physiological Phenomena|Physiology, Cell|Cellular Physiology|Cell Process|cell physiology|Cell Function | Cell physiology |
C1332261 | Paget disease involving the squamous epithelium of the anal canal. | Paget disease of anal canal (disorder)|Anal Canal Paget's Disease|Paget Disease of the Anal Canal|Pagets disease of anal canal|Paget's Disease of Anal Canal|Paget's Disease of the Anal Canal | Paget disease of anal canal |
C1332261 | Paget disease involving the squamous epithelium of the anal canal. | Paget disease of anal canal (disorder)|Anal Canal Paget's Disease|Paget Disease of the Anal Canal|Pagets disease of anal canal|Paget's Disease of Anal Canal|Paget's Disease of the Anal Canal | Paget disease of anal canal |
C0007138 | A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. | carcinomas urothelial|transitional cell carcinoma|TCC - Transitional cell carcinoma|Carcinoma, Transitional Cell|CARCINOMA TRANSITIONAL CELL|Transitional Cell Carcinoma|Urothelial carcinoma|Transitional cell carcinoma (morphologic abnormality)|urothelial carcinoma|Transitional cell carcinoma, NOS|Transitional carcinoma|Transitional Carcinoma|Transitional Cell Carcinomas|Carcinomas, Transitional Cell|CARCINOMA, UROTHELIAL, MALIGNANT|transitional cell carcinomas|transitional carcinoma|Cell Carcinoma, Transitional|Transitional cell carcinoma|carcinoma cell transitional|Cell Carcinomas, Transitional | Carcinoma, Transitional Cell |
C1326205 | Any cellular process that increases the frequency, rate or extent of cell death by apoptosis. | up regulation of apoptosis|upregulation of apoptosis|Induction of Apoptosis|positive regulation of apoptosis|positive regulation of apoptotic process|Apoptosis Induction|induction of apoptosis|up-regulation of apoptosis | Positive Regulation of Apoptosis |
C1510714 | null | null | Aberrant DNA Methylation |
C0025066 | A membrane in the midline of the THORAX of mammals. It separates the lungs between the STERNUM in front and the VERTEBRAL COLUMN behind. It also surrounds the HEART, TRACHEA, ESOPHAGUS, THYMUS, and LYMPH NODES. | Mediastinum, NOS|mediastinum|mediastinal|mediastinal structure|Mediastinal structure|Structure of mediastinum|Mediastinal structure (body structure)|Mediastinal|Mediastinum|MEDIASTINUM|Mediastinal part of chest|Mediastinal (qualifier value) | Mediastinum |
C1512478 | null | Mononuclear Reed-Sternberg Cell Variant|Hodgkin's Cell | Hodgkin Cell |
C0079731 | A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. | cell b lymphoma|Lymphomas Non-Hodgkin's B-Cell|Non-Hodgkin's Lymphoma B-Cell|B-cell lymphoma|b-cell lymphomas|b-cell lymphoma|Non-Hodgkin's B-Cell Lymphoma|B-Cell Non-Hodgkin Lymphoma|B-Cell Non-Hodgkin's Lymphoma|lymphoma b cell|b cells lymphoma|b cell lymphoma non hodgkin's|B Cell Lymphoma|B-cell non-Hodgkin's lymphoma|Lymphoma, non-Hodgkin lymphoma, B-cell|lymphomas non-Hodgkin's B-cell|B-Cell Non Hodgkin's Lymphoma|B-cell lymphoma (clinical)|Malignant lymphoma, B-cell type|B-cell lymphoma, no ICD-O subtype|Lymphoma, B-Cell|non-Hodgkin's lymphoma B-cell|B-cell neoplasm (morphologic abnormality)|Lymphomas, B-Cell|B-cell neoplasm|lymphomas non-hodgkin's b-cell|B-Cell Lymphoma|non-Hodgkin's B-cell lymphoma|B-cell non-Hodgkin lymphoma|B-Cell Lymphomas|B cell lymphoma|b cell lymphomas|b cells lymphomas|B-cell lymphoma (disorder)|lymphoma b-cell|Lymphoma, B Cell|b cell lymphoma|B-Cell non Hodgkin's lymphoma|B-Cell Lymphocytic Neoplasm|B-Cell Neoplasm | B-Cell Lymphomas |
C1333064 | The most common type of Hodgkin lymphoma, which is a cancer of the immune system. Classical Hodgkin lymphoma is marked by the presence of a type of cell called the Reed-Sternberg cell. | Classical Hodgkin's Lymphoma|Classical Hodgkin lymphoma (morphologic abnormality)|Classical Hodgkin lymphoma|Classical Hodgkin Lymphoma|CHL|Classical Hodgkin lymphoma (disorder)|cHL|classical Hodgkin lymphoma|Classic Hodgkin Lymphoma | Classical Hodgkin's Lymphoma |
C0025376 | A narcotic analgesic that can be used for the relief of most types of moderate to severe pain, including postoperative pain and the pain of labor. Prolonged use may lead to dependence of the morphine type; withdrawal symptoms appear more rapidly than with morphine and are of shorter duration. | Meperidina|Pethidine|meperidine|Meperidine|Isonipecain|Pethidin|Product containing pethidine (medicinal product)|Péthidine|Meperidine-containing product|Pethidinum|Pethidine (substance)|pethidine|MEPERIDINE|Isonipecane|Petydyna|4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester|Petidina|Pethidine-containing product | meperidine |
C0012544 | Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. | Product containing bisphosphonate (product)|Bisphosphonate|diphosphonate|Bisphosphonate (substance)|Bisphosphonate-containing product|Bisphosphonates|bisphosphonates|bisphosphonate|Diphosphonate, NOS|Diphosphonate|diphosphonates|Diphosphonates|biphosphonate|Biphosphonate|biphosphonates | Diphosphonates |
C0244404 | The active ingredient in a drug used to reduce the risk of invasive breast cancer in postmenopausal women who are at high risk of the disease or who have osteoporosis. It is also used to prevent and treat osteoporosis in postmenopausal women. It is also being studied in the prevention of breast cancer in certain premenopausal women and in the prevention and treatment of other conditions. Raloxifene blocks the effects of the hormone estrogen in the breast and increases the amount of calcium in bone. It is a type of selective estrogen receptor modulator (SERM). | Raloxifenum|raloxifene|Raloxifeno|RALOXIFENE|Raloxifène|Raloxifene-containing product|(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone|Raloxifene (substance)|Keoxifene|Product containing raloxifene (medicinal product)|Raloxifene | raloxifene |
C0732611 | A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) | Product containing selective estrogen receptor modulator (product)|serms|serm|selective estrogen receptor modulator (SERM)|Estrogen Receptor Modulators, Selective|SERM - Selective estrogen receptor modulator|SERM|Selective estrogen receptor modulator (substance)|Selective Estrogen Receptor Modulator|selective estrogen receptor modulator|SERMs|Selective estrogen receptor modulator|Selective Estrogen Receptor Modulators|Estrogen Receptor Modulator, Selective|Selective Estrogen Receptor Modifying Agents|Selective estrogen receptor modulator-containing product|Selective estrogen receptor modulators | Selective Estrogen Receptor Modulators |
C0080179 | Broken bones in the vertebral column. | Fracture of vertebra|fracture of spine|vertebral fracture|Fracture, Spinal|spinal fractures|spine fracture|Fracture of vertebral column, NOS|SPINE FRACTURE|Spinal Fractures|fractured spine|Spinal Fracture|Vertebral Fracture|Fracture of vertebral column (disorder)|Fracture of spinal vertebra|Fractures, Spinal|Fractured spine|Vertebral fractures|spinal fracture|Fracture of vertebral column|Vertebral fracture|fractured vertebra|Spinal fracture|fracture of vertebra|Fracture of spine|VERTEBRAL FRACTURE | Spinal Fractures |
C0012544 | Organic compounds which contain P-C-P bonds, where P stands for phosphonates or phosphonic acids. These compounds affect calcium metabolism. They inhibit ectopic calcification and slow down bone resorption and bone turnover. Technetium complexes of diphosphonates have been used successfully as bone scanning agents. | Product containing bisphosphonate (product)|Bisphosphonate|diphosphonate|Bisphosphonate (substance)|Bisphosphonate-containing product|Bisphosphonates|bisphosphonates|bisphosphonate|Diphosphonate, NOS|Diphosphonate|diphosphonates|Diphosphonates|biphosphonate|Biphosphonate|biphosphonates | Diphosphonates |
C0003241 | Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS). | Antibody|Antibody-containing product|Antibodies|antibodies|Antibody, NOS|antibody|Ab|Antibody (substance)|Product containing antibody (product) | Antibodies |
C0006837 | A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). | Candida stellatoidea (organism)|Candida albicans (organism)|Myceloblastanon albicans|Saccharomyces albicans|CA - Candida albicans|Procandida stellatoidea|Candida albicans|C. albicans|Oidium albicans|Candida Albicans|Monilia albicans|Mycotorula albicans|Candida albicans var albicans (organism)|Candida albican|Candida albicans var albicans|CANDIDA ALBICANS|Candida albicans var. stellatoidea|albicans, Candida|Monilia stellatoidea|Parasaccharomyces albicans|Syringospora albicans|Candida stellatoidea type I|Candida stellatoidea|candida albicans|Dematium albicans|monilia albicans|Procandida albicans|Candida albicans var stellatoidea | Candida albicans |
C0600449 | Those genes found in an organism which are necessary for its viability and normal function. | Essential Gene|Essential Genes|Gene, Essential | Genes, Essential |
C0008662 | A specific pair of human chromosomes in group A (CHROMOSOMES, HUMAN, 1-3) of the human chromosome classification. | 2 chromosomes|Chromosome pair 2|chromosome 2|Chromosomes, Human, Pair 2|Chromosome 2|2 chromosome|Chromosome pair 2 (cell structure) | Chromosomes, Human, Pair 2 |
C0036864 | Sexual activities of humans. | sexual behaviour|sexual behaviors|Sexual behavior|Sexual Behavior|sex behavior|sexuality|Sexually|Activity, Sexual|Sex|Sexual behaviour, NOS|Sexual Activities|Finding relating to sexual behavior or practice (finding)|Sexual behaviour|Behavior, Sexual|Sexual Activity|Activities, Sexual|Sexual behavior (observable entity)|Finding relating to sexual behaviour or practice|Sexual|Sexual behavior, NOS|sexual activities|Behavior, Sex|sexual activity|sexual behavior|Finding relating to sexual behavior or practice|Sex Behavior|Sexual States|sexual relations|SEXUAL BEHAVIORS | Sex Behavior |
C0442592 | A health care facility where patients are admitted to get treatment provided by a group of physicians practicing medicine together. | clinics|Clinic|CLINIC|Clinic (environment)|CLINIC - WALK IN, OTHER|clinic|Clinics | Clinic |
C0086287 | An individual who reports belonging to the cultural gender role distinction of female. | Female|F|Female, NOS|Female Gender, Self Reported|Female structure|Females|Female gender|female|female sex|females|Female structure (body structure)|Sex Female|Female Gender|FEMALE SEX|Female Gender, Self Report|Female individual|Female individual, NOS|FEMALE|Female (finding) | Females |
C0001948 | Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. | ALCOHOL INGESTION|drinking|AI - Alcohol intake|intake alcohol|alcohol uses|consumption alcohol|drinking alcohol|Drinking Habit, Alcohol|ETOH - Alcohol intake|alcoholic beverage consumption|alcohol consumption|alcohol ingestion|Alcohol intake|Drinking Habits, Alcohol|Alcohol intake (observable entity)|Consumption, Alcohol|etoh use|alcohol quantity/frequency|Drinking|Alcohol Drinking Habit|Alcoholic drink intake|drink alcohol|ALCOHOL USE|alcohol use|Drinking, Alcohol|ETOH USE|Alcohol consumption|Alcohol Drinking|Alcohol Consumption|Drinking, alcohol|Ethanol intake|ALCOHOL CONSUMPTION|Habit, Alcohol Drinking|alcohol intake|Alcohol Drinking Habits|Habits, Alcohol Drinking | Alcohol consumption |
C0005001 | <p>The prostate is a gland in men. It helps make semen, the fluid that contains sperm. The prostate surrounds the tube that carries urine out of the body. As men age, their prostate grows bigger. If it gets too large, it can cause problems. An enlarged prostate is also called benign prostatic hyperplasia (BPH). Most men will get BPH as they get older. Symptoms often start after age 50.</p> <p>BPH is not cancer, and it does not seem to increase your chance of getting prostate cancer. But the early symptoms are the same. Check with your doctor if you have</p> <ul> <li>A frequent and urgent need to urinate, especially at night</li> <li>Trouble starting a urine stream or making more than a dribble</li> <li>A urine stream that is weak, slow, or stops and starts several times</li> <li>The feeling that you still have to go, even just after urinating</li> <li>Small amounts of blood in your urine</li> </ul> <p>Severe BPH can cause serious problems over time, such as urinary tract infections, and bladder or kidney damage. If it is found early, you are less likely to develop these problems.</p> <p>Tests for BPH include a digital rectal exam, blood and imaging tests, a urine flow study, and examination with a scope called a cystoscope. Treatments include watchful waiting, medicines, nonsurgical procedures, and surgery.</p> <p class="">NIH: National Institute of Diabetes and Digestive and Kidney Diseases</p> | Benign Prostatic Hypertrophy|Benign enlargement of prostate, NOS|benign prostate hypertrophy|prostate hypertrophy|Prostatic Hyperplasia|prostatic hypertrophy|Prostatic Hypertrophy, Benign|bph|BPH|benign prostatic hypertrophy|benign enlarged prostate|Hypertrophy, Benign Prostatic|benign prostate enlargement|Enlarged Prostate (BPH)|BEP - Benign enlargement of prostate|Benign enlargement of prostate|PROSTATE, HYPERTROPHY, BENIGN|Benign prostatic hypertrophy|Hypertrophy (benign) of prostate|Benign hypertrophy of prostate NOS | Benign prostatic hypertrophy |
C0001641 | Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. | adrenergic alpha receptor blockaders|Alpha-adrenergic blocking agent, NOS|Adrenergic alpha blockers|Alpha adrenergic receptor antagonist|adrenergic agent alpha blocking|Product containing alpha adrenergic receptor antagonist (product)|Alpha-adrenergic Blocking Agent|alpha-Adrenergic Blocking Agents|Substance with alpha adrenergic receptor antagonist mechanism of action|Agents, alpha-Adrenergic Blocking|Adrenergic alpha Blockers|Alpha-adrenergic Blocking Agents|Alpha Blocker|alpha blocker|alpha-blocker|Adrenergic alpha-Antagonists|Alpha adrenergic receptor antagonist-containing product|alpha Blockers, Adrenergic|alpha adrenergic blockers|alpha-Blockers, Adrenergic|alpha antiadrenergic agent|Blockaders, Adrenergic alpha-Receptor|agent alpha adrenoceptor blocking|Adrenergic alpha Antagonists|alpha-adrenergic blocking agents|Blockers, alpha-Adrenergic|Adrenergic alpha-Blockers|alpha-adrenergic blockers|Adrenergic alpha-Receptor Blockaders|Substance with alpha adrenergic receptor antagonist mechanism of action (substance)|alpha adrenergic blocker|alpha-adrenergic antagonist|alpha-adrenergic receptor blockaders|alpha adrenergic antagonists|alpha-Antagonists, Adrenergic|alpha adrenergic blocking agents|alpha Adrenergic Antagonists|Blockaders, alpha-Adrenergic Receptor|alpha-Adrenergic Receptor Blockaders|Adrenergic alpha Receptor Blockaders|adrenergic alpha blockers|Blocking Agents, alpha-Adrenergic|alpha-Adrenergic Blockers|Antagonists, alpha-Adrenergic|alpha Adrenergic Receptor Blockaders|alpha-Adrenergic Antagonists|alpha Adrenergic Blockers|Receptor Blockaders, alpha-Adrenergic|Alpha-Adrenergic Antagonist|alpha-Receptor Blockaders, Adrenergic|alpha Adrenergic Blocking Agents|alpha blockers | Adrenergic alpha-Antagonists |
C0878773 | Symptom of overactive detrusor muscle of the URINARY BLADDER that contracts with abnormally high frequency and urgency. Overactive bladder is characterized by the frequent feeling of needing to urinate during the day, during the night, or both. URINARY INCONTINENCE may or may not be present. | hypertonic bladder|Overactive Urinary Bladder|bladder overactive|Hypertonicity of bladder|Hyperactivity of bladder|hyperactivity bladder|hyperactive bladder|Bladder instability|bladders overactive|Hypertonic bladder|Urinary Bladder, Overactive|overactive bladder|Hyperactive bladder|Overactive Bladder|bladder hyperactive|Overactive bladder|Overactive bladder (disorder)|Bladder, Overactive|Instability of bladder | Overactive Bladder |
C0242896 | Any agent that binds to and blocks nicotinic and/or muscarinic receptors, thereby preventing the actions of the neurotransmitter acetylcholine (Ach) at these receptors. | ANTICHOLINERGIC AGENTS|Anticholinergic Agents|Anticholinergics|Anticholinergic Agent|Substance with acetylcholine receptor antagonist mechanism of action|Anticholinergic drug|Acetylcholine receptor antagonist|Anti Cholinergics|anticholinergic|anticholinergics|Agents, Anticholinergic|anticholinergic drugs|anticholinergic drug|anticholinergic agent|Anticholinergic agent, NOS|Anticholinergic Drugs|anticholinergic agents|Product containing acetylcholine receptor antagonist (product)|Substance with acetylcholine receptor antagonist mechanism of action (substance)|Acetylcholine receptor antagonist-containing product|Anti-Cholinergics | Anticholinergic Agents |
C0870221 | null | Boy|Male child|boys|Male child (person)|boy | Boys |
C0406817 | null | Familial cutaneous collagenoma|COLLAGENOMA, FAMILIAL CUTANEOUS|Familial cutaneous collagenoma (disorder) | Collagenoma, Familial Cutaneous |
C0265978 | null | Collagen nevus of skin (disorder)|collagenomas|collagenoma|Collagen nevus of skin|Collagenomas|Collagen nevus|Collagenoma|Collagen naevus of skin|Collagenous nevus|Collagen naevus | Collagen nevus of skin |
C1280632 | null | Entire trunk (body structure)|Entire torso region|Entire trunk | Entire trunk |
C1305761 | null | Entire masseter (body structure)|Entire masseter | Entire masseter |
C0006050 | A drug used to treat certain medical conditions. These include severe underarm sweating and severe muscle spasms in the neck and shoulders. OnabotulinumtoxinA is also used to smooth wrinkles on the face. It is being studied in the treatment of pain in patients with skin leiomyomas (benign smooth muscle tumors) and other conditions. It is a form of a toxin made by the bacterium Clostridium botulinum.. | botulinum toxin A|toxin botulinum type a|BOTULINUM TOXIN TYPE A|botulinum toxin type A|Botulinum toxin type A (substance)|botulinum neurotoxin type A|Neurotoxin A, Botulinum|Botulinum toxin A|Clostridium botulinum A Toxin|Botulinum A Toxin|botulinum toxin type|Botulinum A neurotoxin|Botulinum Neurotoxin Type A|Toxin, Botulinum A|botulinum toxin type a|Botulinum Toxins, Type A|DaxibotulinumtoxinA|botulinum A toxin|Botulinum toxin type A-containing product|Botulinum Neurotoxin A|Product containing botulinum toxin type A (medicinal product)|Botulinum Toxin Type A|Toxine botulinique A|Clostridium Botulinum Toxin Type A|Botulinum toxin type A|botulinum a toxin|Toxina botulínica A|Botulinum Toxin A|BTX-A|botulinum toxin a | botulinum toxin type A |
C0020564 | General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA). | hypertrophy|hypertrophied|enlargement|hypertrophies|Hypertrophies|enlargements|Enlargement|Hypertrophy, NOS|Enlargement, NOS|Hypertrophy|HYPERTROPHY|HYPERTROPHIES|Hypertrophic|hypertrophic|Hypertrophy (morphologic abnormality) | Hypertrophy |
C0341000 | Selective grinding of occlusal surfaces of the teeth in an effort to eliminate premature contacts and occlusal interferences; to establish optimal masticatory effectiveness, stable occlusal relationships, direction of main occlusal forces, and efficient multidirectional patterns, to improve functional relations and to induce physiologic stimulation of the masticatory system; to eliminate occlusal trauma; to eliminate abnormal muscle tension; to aid in the stabilization of orthodontic results; to treat periodontal and temporomandibular joint problems; and in restorative procedures. (From Jablonski, Dictionary of Dentistry, 1992) | occlusal adjustment|Occlusal equilibration|Equilibrations, Occlusal|Adjustment, Occlusal|Occlusal adjustment|Occlusal Adjustments|Occlusal equilibration (procedure)|Occlusal adjustment (procedure)|Occlusal Adjustment|occlusal equilibration|Adjustments, Occlusal|Occlusal Equilibration | Occlusal Adjustment |
C0019621 | A group of disorders resulting from the abnormal proliferation of and tissue infiltration by LANGERHANS CELLS which can be detected by their characteristic Birbeck granules (X bodies), or by monoclonal antibody staining for their surface CD1 ANTIGENS. Langerhans-cell granulomatosis can involve a single organ, or can be a systemic disorder. | hand schuller christian disease|Type 2 Histiocytosis|Langerhans cell histiocytosis, poly-ostotic|Histiocytosis, Generalized|Hand-Schuller-Christian disease|Chronic histiocytosis X|Letterer-Siwe Disease|Multifocal and unisystemic Langerhans cell histiocytosis|Schüller-Christian syndrome|Hand Schüller Christian Syndrome|langerhans cell disease|Reticuloendotheliosis, Systemic Aleukemic|cell histiocytosis langerhans|SCHUELLER-CHRISTIAN DISEASE|Reticuloendotheliosis, Non-Lipid|Non-Lipid Reticuloendothelioses|Langerhans cell histiocytosis, multifocal|Generalized Histiocytoses|Langerhans Cell Histiocytosis|Cell Granulomatosis, Langerhans|Hand-Schueller-Christian Syndrome|generalized histiocytosis|Schueller Christian Disease|Histiocytosis, Langerhans-Cell|Systemic Aleukemic Reticuloendothelioses|Disease, Hand-Schueller-Christian|Hand Schueller Christian Syndrome|Chronic idiopathic xanthomatosis|Non Lipid Reticuloendotheliosis|Generalised histiocytosis of bones|cell granulomatosis langerhans|Langerhans Cell Histiocytosis, NOS|Cell Granulomatoses, Langerhans|Langerhans cell histiocytosis, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|Granulomatoses, Langerhans Cell|Langerhans-Cell Histiocytosis|Langerhans cell histiocytosis, no International Classification of Diseases for Oncology subtype|Reticuloendothelioses, Systemic Aleukemic|Hand-Schüller-Christian disease (disorder)|hand-schuller-christian disease|Disease, Schueller-Christian|Hand-Schueller-Christian syndrome|histiocytosis X|Langerhans-Cell Granulomatosis|LCH|Cell Histiocytoses, Langerhans|Generalized Histiocytosis|Granulomatosis, Langerhans-Cell|Schueller-Christian Disease|Langerhans Cell Granulomatosis|Letterer Siwe Disease|histiocytosis-x|Hand Schuller Christian disease|Hand Schueller Christian Disease|Hand-Schüller-Christian disease|LANGERHANS CELL HISTIOCYTOSIS|langerhans cell histiocytosis|Hand-Schuller-Christian Disease|Langerhans cell disease|Histiocytosis-X|Chronic differentiated progressive histiocytosis|Multifocal Unisystem Langerhans Cell Histiocytosis|Disease, Hand-Schüller-Christian|Systemic Aleukemic Reticuloendotheliosis|HAND-SCHUELLER-CHRISTIAN SYNDROME|Langerhan's cell histiocytosis|cell histiocytosis langerhan|Cell Histiocytosis, Langerhans|Systemic reticuloendothelial granuloma|Hand Schüller Christian Disease|Chronic disseminated histiocytosis X|Syndrome, Hand-Schueller-Christian|Type 2 Histiocytoses|Histiocytosis, Langerhans Cell|Langerhans cell granulomatosis|christian diseases hand schuller|Langerhans cell histiocytosis|disease hand schuller christian|LCH - Langerhan's cell histiocytosis|Langerhans cell histiocytosis, no ICD-O subtype|Differentiated progressive histiocytosis|schuller christian syndrome|Histiocytosis, Type 2|Chronic Histiocytosis X|hand christian schuller disease|Syndrome, Hand-Schüller-Christian|cells histiocytosis langerhans|Langerhans cell histiocytosis (disorder)|hand-schueller-christian disease|Disease, Letterer-Siwe|Langerhans cell histiocytosis, multifocal (morphologic abnormality)|Hand-Schüller-Christian Disease|HISTIOCYTOSIS X II|Histiocytosis X|langerhan's cell histiocytosis|Histiocytosis X syndrome (disorder)|EOSINOPHILIC GRANULOMA, MULTIFOCAL|Generalized histiocytosis of bones|Aleukemic Reticuloendotheliosis, Systemic|Histiocytoses, Langerhans Cell|Langerhans Cell Histiocytosis, Not Otherwise Specified|Classic Multifocal Langerhans Cell Histiocytosis|Langerhans Cell Histiocytoses|christian disease hand schuller|Non-Lipid Reticuloendotheliosis|Schuller-Christian syndrome|Hand-Schueller-Christian Disease|Langerhans cell histiocytosis, polyostotic|Histiocytoses, Type 2|langerhans cell granulomatosis|Reticuloendothelioses, Non-Lipid|histiocytosis x|Histiocytosis X syndrome|Langerhans Cell Granulomatoses|Histiocytosis X, NOS|Histiocytoses, Generalized|Hand-Schüller-Christian Syndrome|Granulomatosis, Langerhans Cell|Aleukemic Reticuloendothelioses, Systemic | Histiocytosis, Langerhans-Cell |
C0151332 | null | Active tuberculosis|Tuberculosis, active|Active Tuberculosis|Active tuberculosis (disorder)|active tuberculosis | Active tuberculosis |
C0023775 | Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. | Peroxidation, Lipid|Lipid peroxidation, function (observable entity)|Lipid Peroxidations|Peroxidations, Lipid|Lipid peroxidation, function|Lipid peroxidation|lipid peroxidation|Lipid Peroxidation | Lipid Peroxidation |
C0038454 | A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) | Cerebrovascular accident (disorder)|Strokes, Cerebral|cerebral stroke|Stroke, Cerebral|Syndrome, Stroke|Brain Attack|UNDETERMINED STROKE|Cerebrovascular accident|Cerebrovascular Strokes|Apoplexy, NOS|APOPLEXY, CEREBRAL|Stroke Syndrome|Cerebral apoplexy, NOS|Cerebral Stroke|stroke cerebral|CVA|Stroke, Cerebrovascular|Cerebrovascular accident, NOS|Brain Vascular Accident|APOPLEXY|STROKE|Brain attack|CVA (cerebral vascular accident)|cerebrovascular stroke|Strokes|CVA, Cerebrovascular Accident|Cerebrovascular Apoplexy|Stroke, cerebrovascular|Cerebrovascular Stroke|cerebrovascular accidents|CVA, NOS|Cerebral Strokes|Cerebral vascular events|stroke|CVAs (Cerebrovascular Accident)|Cerebrovascular Accidents|Strokes, Cerebrovascular|CEREBRAL VASCULAR ACCIDENT|Stroke, neurological|Brain Vascular Accidents|Vascular Accident, Brain|CEREBROVASCULAR ACCIDENT|Stroke|vascular cerebral accident|Apoplexy|cerebral vascular accident|strokes|Cerebrovascular accidents|ACCIDENT CEREBROVASCULAR|Stroke, NOS|CVA (Cerebrovascular Accident)|Cerebrovascular Accident, (CVA)|Vascular Accidents, Brain|vascular brain accident|cerebrovascular accident|apoplexy|Apoplexy, Cerebrovascular|CVA - Cerebrovascular accident|Cerebrovascular Accident | Cerebrovascular accident |
C0002949 | An aneurysm caused by a tear in the TUNICA INTIMA of a blood vessel leading to interstitial HEMORRHAGE, and splitting (dissecting) of the vessel wall, often involving the AORTA. Dissection between the tunica intima and TUNICA MEDIA causes luminal occlusion. Dissection at the media, or between the media and the outer ADVENTITIA causes aneurismal dilation. | arterial dissection|dissection arterial|Dissecting aneurysm|dissecting aneurysm|arteries dissection|Arterial Dissection|aneurysm dissecting|Arterial dissection|artery dissecting aneurysm|Dissection of artery (disorder)|Arterial dissections|ANEURYSM, DISSECTING|Dissection of artery|artery dissection|Dissecting Aneurysms|Dissecting aneurysm of artery, NOS|Aneurysm, dissecting|Aneurysms, Dissecting|Dissecting Aneurysm|arterial dissections|dissecting aneurysms | Aneurysm, Dissecting |
C0521654 | Loss of movement function. | neurological impairment|Motor deficits|dysfunctions motor|central deficits nervous system|deficits neurological|Motor Deficit|Deficits, Neurologic|deficits motor|Motor dysfunction (finding)|Neurological deficit|deficits neurologic|motor deficit|Neurological deficit (finding)|Neurologic Deficit|Motor Deficits|Motor deficit|Neurologic deficit, NOS|neurologic deficit|motor dysfunction|Deficit, Neurologic|impairments neurological|dysfunction motor|neurologic deficits|Motor dysfunction|Motor dysfunction, NOS|Neurologic deficit|neurological deficit | Neurologic Deficits |
C0007820 | A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others. | Unspecified cerebrovascular disease|Cerebrovascular disease|Vascular Disorder, Brain|Cerebrovascular Disorder|cvd|Vascular Diseases, Intracranial|Cerebrovascular Diseases|CEREBROVASCULAR DISEASE|CVD - Cerebrovascular disease|Intracranial Vascular Diseases|Brain Vascular Disorder|Cerebrovascular disease (disorder)|Disease, Cerebrovascular|Brain Vascular Disorders|Vascular Disorders, Intracranial|Diseases, Cerebrovascular|cerebrovascular disease|cerebrovascular diseases|Intracranial Vascular Disorder|Cerebrovascular lesion, NOS|CEREBROVASCULAR DISORDER|Cerebrovascular disease or lesion NOS|CEREBROVASCULAR DISORDER (NOS)|Intracranial Vascular Disorders|Vascular Disorders, Brain|Vascular Disorder, Intracranial|Cerebrovascular Disorders|cerebral vascular disorder|Vascular Disease, Intracranial|CEREBROVASCULAR DISEASES|CEREBRAL VASCULAR DISTURBANCE (NOS)|Intracranial Vascular Disease|Cerebrovascular Disease|cerebral vascular disorders|cerebrovascular disorders|cerebrovascular disorder|Cerebrovascular disease, NOS|CEREBRAL VASCULAR LESION (NOS)|DISORDER CEREBROVASCULAR | Cerebrovascular Disorders |
C0459922 | null | intracranial vessels|Intracranial vessel|Intracranial vascular structure (body structure)|intracranial vascular structure | Intracranial vascular structure |
C0042373 | Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. | vascular diseases|VASCULAR PROBLEM, NOS|vascular disorder|VASCULAR PROBLEM|vascular disorders|Angiopathy|Vascular disease or syndrome|Vascular disease|VASCULAR DISORDER|Vascular Disorder|Disorder of blood vessel (disorder)|vascular disease|Disease, Vascular|blood vessel disorder|vascular problem|Diseases, Vascular|Vascular disorder, NOS|Vascular disease, NOS|blood vessel disease|Disorder of blood vessel|Vascular Diseases and Syndromes|Vascular Disorders|Blood-vessels--Diseases|Vasculopathy|Vascular disorder|Vascular Diseases|VASCULAR DISEASES|Vascular Disease|DISORDER VASCULAR|angiopathy|Angiopathy, NOS | Vascular Diseases |
C0008107 | A country in southern South America, bordering the South Pacific Ocean, between Argentina and Peru. | Chile|chiles|CHL|CL|CHILE|Chile (geographic location)|chile | Chile |
C0008711 | Chronic inflammation of the nasal cavity mucosa. It may lead to post-nasal drip resulting in chronic sore throat and chronic cough. | rhinitis chronic|Chronic rhinitis|Chronic rhinitis (disorder)|Chronic Rhinitis|chronic rhinitis | Chronic rhinitis |
C0013444 | The narrow passage way that conducts the sound collected by the EAR AURICLE to the TYMPANIC MEMBRANE. | auditory canal|Ear Canal, External|Ear Canals|Canals, External Ear|External ear canal|External Auditory Canals|ear canal|external auditory meatus|External auditory canal, NOS|External auditory meatus|External acoustic meatus|Ear Canal|External Ear Canals|EAR CANAL|ear canals|Ear Canals, External|External Acoustic Canal|External auditory canal structure (body structure)|External acoustic tube|Auditory canal, NOS|Auditory canal|Meatus acusticus externus|Canal, External Ear|EXTERNAL AUDITORY CANAL|external auditory canal|Acoustic Meatus, External|external acoustic meatus|External auditory tube|Auditory Canal, External|Canals, Ear|Auditory Canals, External|Ear canal|External Auditory Canal|Acoustic Canals, External|External Acoustic Canals|External auditory canal structure|Canal, Ear|External Ear Canal|Acoustic Canal, External|External Acoustic Meatus|External auditory canal | External auditory canal structure |
C0027428 | The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. | Nasal mucosa|Mucosa of nose|Structure of mucous membrane of nose|nasal mucosa|Structure of mucous membrane of nose (body structure)|Tunica mucosa nasi|Mucous membrane of nose|nasal membrane|mucosa nasal|Nasal Mucosa|Mucosa, Nasal|membranes nasal | Structure of mucous membrane of nose |
C0150866 | Removal of a portion of skin tissue, for microscopic examination. | of skin biopsy|Biopsy of skin (procedure)|biopsies skin|Skin Biopsy|Biopsy of Skin|Biopsy of skin|Skin biopsy|biopsy skin|skin biopsy | Biopsy of skin procedure |
C0013295 | A PEPTIC ULCER located in the DUODENUM. | duodenal ulcers|Duodenal ulcer disease, NOS|DUODENAL ULCER DISEASE|Ulcer of duodenum|duodenal ulceration|duodenum ulcers|Ulcer, Duodenal|Duodenal ulcer, NOS|du|DU - Duodenal ulcer|DUODENAL ULCER|DUODENAL ULCERATION|Duodenum--Ulcers|Duodenal ulcer (diagnosis)|Common duodenal ulcer, NOS|duodenum ulcer|Duodenal ulcer disease|ULCER DUODENAL|DUD - Duodenal ulcer disease|DUODENUM, ULCER|Ulcer of duodenum (disorder)|Duodenal Ulcer|DUODENUM, PEPTIC ULCER|Duodenal Ulcers|Peptic ulcer of duodenum, NOS|Duodenal ulcers|duodenal ulcer|Duodenal ulcer|Ulcers, Duodenal | Duodenal Ulcer |
C0041909 | Bleeding originating from the upper gastrointestinal tract (oral cavity, pharynx, esophagus, and stomach). | Upper GI - gastrointestinal hemorrhage|Upper gastrointestinal hemorrhage|Upper GI hemorrhage|bleeding gi upper|upper gastrointestinal bleed|upper gastrointestinal bleeding|bleed ugi|upper gi hemorrhage|bleeds ugi|Upper Gastrointestinal Hemorrhage|Upper gastrointestinal bleeding|upper gi haemorrhage|gi haemorrhage upper|bleed gastrointestinal upper|bleeding gastrointestinal upper|Upper GI haemorrhage|upper gi bleed|upper gi bleeding|bleed gi upper|Upper gastrointestinal haemorrhage|bleeding ugi|ugi bleed|UPPER GASTROINTESTINAL BLEEDING|bleeds gi upper|Upper GI - gastrointestinal haemorrhage|Upper GI bleeding|Upper gastrointestinal hemorrhage (disorder) | Upper gastrointestinal hemorrhage |
C0035359 | An area occupying the most posterior aspect of the ABDOMINAL CAVITY. It is bounded laterally by the borders of the quadratus lumborum muscles and extends from the DIAPHRAGM to the brim of the true PELVIS, where it continues as the pelvic extraperitoneal space. | back of the abdomen cavity|Retroperitoneal compartment|Retroperitoneal Spaces|retroperitoneal space|Retroperitoneal|Structure of retroperitoneal space (body structure)|retroperitoneal|Retroperitoneal Space|Retroperitoneal compartment structure|Retroperitoneal Cavity|Spatium retroperitoneale|Retroperitoneal compartment structure (body structure)|Retroperitoneal (qualifier value)|Retroperitoneal space|Structure of retroperitoneal space|Space, Retroperitoneal|Retroperitoneal space, NOS|RETROPERITONEUM|retroperitoneum|Retroperitoneum, NOS|Retroperitoneum|retroperitoneal structures|Spaces, Retroperitoneal | Retroperitoneal Space |
C0031139 | Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure. | peritoneal dialyses|Peritoneal dialysis|PERITONEAL DIALYSIS|dialysis peritoneal dialysis|Peritoneal dialysis (procedure)|Dialyses, Peritoneal|Peritoneal Dialyses|peritoneal dialysis|Peritoneal Dialysis|dialysis peritoneal|PD - Peritoneal dialysis|Peritoneal dialysis, NOS|Dialysis, Peritoneal | Peritoneal Dialysis |
C0019061 | A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. | RENAL THROMBOTIC THROMBOCYTOPENIC PURPURA <HEMOLYTIC UREMIC SYNDROME>|hemolytic-uremic syndrome (HUS)|kidney ttp|GASSER SYNDROME|Haemolytic uraemic syndrome|Hemolytic uremic syndrome (disorder)|HUS|Hemolytic Uremic Syndrome|Gasser's syndrome|hemolytic-uremic syndrome|kidney thrombotic thrombocytopenic purpura hemolytic uremic syndrome|hemolytic uremic syndrome|SYNDROME HEMOLYTIC UREMIC|renal ttp|Hemolytic-Uremic Syndrome|Gassers Syndrome|gasser syndrome|HUS - Haemolytic uraemic syndrome|HUS - Hemolytic uremic syndrome|Hemolytic uremic syndrome|haemolytic-uraemic syndrome|Hemolytic uremic syndrome, NOS|Syndrome, Hemolytic-Uremic|HEMOLYTIC UREMIC SYNDROME|Hemolytic-uremic syndrome|Gasser Syndrome|Gasser's Syndrome|RENAL THROMBOTIC THROMBOCYTOPENIC PURPURA HEMOLYTIC UREMIC SYNDROME|HEMOLYTIC-UREMIC SYNDROME|Haemolytic uraemic syndrome, NOS | Hemolytic-Uremic Syndrome |
C0021839 | Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. | mucosa intestinal|Intestinal mucosa|intestinal membrane mucous|mucosa intestine|Intestinal mucous membrane|Intestinal mucous membrane structure|intestinal mucosa|Intestinal mucous membrane, NOS|Intestinal mucosa, NOS|Mucosa of intestine|intestines mucosa|Intestinal Mucosa|Intestinal mucous membrane structure (body structure)|Mucosa, Intestinal|intestine mucosa | Intestinal Mucosa |
C0010346 | A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. | Cicatrizing enterocolitis|crohn diseases|disease crohn's|enteritis (regional)|Regional enteritis|Crohn Disease|Crohn's Disease|Crohns Disease|Granulomatous enteritis|Crohn's disease (disorder)|granulomatous enteritis|Crohns disease|Regional enteritis (Crohn's disease)|Crohn's Enteritis|disease crohn|crohns diseases|CD - Crohn's disease|crohn's diseases|CROHN DISEASE|eleocolitis|DISEASE CROHNS|regional enteritis|Morbus Crohn|Crohn's disease|Crohn's|Crohn disease|crohns's disease|CROHN'S DISEASE|IBD1|crohn s|Regional enteritis, NOS|Granulomatous enteritis, NOS|Inflammatory Bowel Disease 1|Crohn's regional enteritis|crohns disease|Crohn's disease, NOS|Regional enterocolitis|Crohn's disease NOS|crohns's|crohn s disease|Regional Enteritis|RE - regional enteritis|REGIONAL ENTERITIS|INFLAMMATORY BOWEL DISEASE, REGIONAL ENTERITIS|Granulomatous enteritis and colitis|enteritis regional|INFLAMMATORY BOWEL DISEASE (CROHN DISEASE) 1|crohn's disease|regional enterocolitis | Crohn Disease |
C0151686 | Stature that is smaller than normal as expected for age. | Growth suppression|GROWTH RETARDATION|retarded growth|Growth retardation (disorder)|Decreased growth|Growth retardation, NOS|GROWTH RETARDED|Growth suppression, NOS|Growth retardation (morphologic abnormality)|Growth Retardation|Retarded growth|growth suppression|Growth retardation|Decreased growth, NOS|growth retardation | Growth retardation |
C1452968 | null | null | Androgenization |
C0024032 | A birth weight that is less than 2500 grams. | Low birthweight|BIRTH WEIGHT SUBNORMAL|Low birthweight for gestational age|Low Birth Weight|Birth weight, Low|low birth weight|Low birth weight|birth low weights|low birth weights|low weight birth|BIRTHWEIGHT SUBNORMAL|birth weight low|Birth Weights, Low|Subnormal birth weight|BIRTH WEIGHT LOW|Low Birth Weights|birth low weight|births low weight|low birthweight|Birth Weight, Low|WEIGHT BIRTH SUBNORMAL | Low Birth Weights |
C0260271 | null | null | Therapeutics, Surgical |
C1029630 | null | null | Baccharis dracunculifolia |
C1006580 | null | Oryzomys subflavus (organism)|Terraced rice rat|terraced rice rat|Cerradomys subflavus|Oryzomys subflavus | Oryzomys subflavus |
C0022345 | null | Coturnix japonica japonica|Coturnix japonica (organism)|Coturnix coturnix japonica|Coturnix coturnix Japonicus|Quails, Japanese|Coturnix japonica|Japanese quail|Japanese Quails|Coturnix coturnix japanica|Quail, Japanese | Japanese Quail |
C0065846 | a kind of weed killer | 2-methyl-4-chlorophenoxypropionic acid|2-(4-chloro-2-methylphenoxy)propionic acid|Mecoprop|mcpp|mecoprop|2-(4-chloro-2-methylphenoxy)propanoic acid (substance)|2-(4-chloro-2-methylphenoxy)propanoic acid|MCPP - 2-(4-chloro-2-methylphenoxy)propanoic acid|MCPP | mecoprop |
C0043094 | Increase in BODY WEIGHT over existing weight. | weight gain|increasing weight|Weight gain (finding)|increased weight|Increased weight|Weight gain|increases weight|Weight increased (finding)|Measured weight gain (observable entity)|increase weight|Measured weight gain|Weight Gains|gain wt|Gain, Weight|Gains, Weight|gains weight|Increased body weight|Weight increased|Weight increasing|Body Weight Gain|weight gaining|WEIGHT INCREASE|gained weight|BWGAIN|Weight Gain|Weight increasing (finding)|gaining wt|Weight Increase|WEIGHT GAIN|gain weight|wt gain|weight increase | Weight Gain |
C0030493 | A poisonous dipyridilium compound used as contact herbicide. Contact with concentrated solutions causes irritation of the skin, cracking and shedding of the nails, and delayed healing of cuts and wounds. | 4,4'-Bipyridinium, 1,1'-dimethyl-|Paraquat|Methyl Viologen|Paraquat (substance)|Viologen, Methyl|paraquat | Paraquat |
C0026817 | A family of the order DIPTERA with over 700 species. Important species that may be mechanical vectors of disease include Musca domesticus (HOUSEFLIES), Musca autumnalis (face fly), Stomoxys calcitrans (stable fly), Haematobia irritans (horn fly) and Fannia spp. | Family Muscidae (organism)|FAMILY MUSCIDAE|Muscidae|Family Muscidae | Muscidae |
C1036965 | null | Shiny Cowbird|Molothrus bonariensis (organism)|Molothrus bonariensis | Molothrus bonariensis |
C1195817 | null | Chalk-browed mockingbird|Mimus saturninus|Mimus saturninus (organism) | Mimus saturninus |
C1012792 | null | Tubastrea | Tubastraea |
C0050079 | A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin. | 8-OH-DPAT|1-Naphthalenol, 7-(dipropylamino)-5,6,7,8-tetrahydro- | 8-Hydroxy-2-(di-n-propylamino)tetralin |
C1005664 | null | null | Daphnia similis |
C0005507 | A method of measuring the effects of a biologically active substance using an intermediate in vivo or in vitro tissue or cell model under controlled conditions. It includes virulence studies in animal fetuses in utero, mouse convulsion bioassay of insulin, quantitation of tumor-initiator systems in mouse skin, calculation of potentiating effects of a hormonal factor in an isolated strip of contracting stomach muscle, etc. | Bioassays|Bioassay (procedure)|Assay, Biological|Assays, Biologic|Assays, Biological|Bioassay|Biological Assay|Biologic Assays|bioassays|Assay|bioanalytical assays|Biological Assays|Assay, Biologic|Biologic Assay|Biological assay|Bioassay, NOS|bioassay | Biological Assay |
C0018889 | Infestation with parasitic worms of the helminth class. | Helminthiases|helminth infections|HELMINTHIASES|worm infection|Infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata|helminthiasis|Helminth infection, NOS|Helminth infection|Worm infestation|Worms|worm infestation|Helminth infection, unspecified|Worms NOS|helminthic infections|Infection caused by Class Cestoda and/or Class Trematoda and/or Phylum Nemata|Worm infection|helminthic infection|Helminthosis|helminth infection|helminth parasite infection|Infection caused by Class Cestoda and/or Class Trematoda and/or Phylum Nemata (disorder)|HELMINTHIC INFECTIONS: GENERAL TERMS|Worms, NOS|Helminthiasis|HELMINTHIASIS|worms infestation|WORM|helminthiases|Helminthiasis NOS|HELMINTHIC INFECTIOUS DISEASES | Helminthiasis |
C1087537 | null | null | Palicourea crocea |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.